State Street’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
DCP
State Street's AGL Position: Q2 2026 in Review
State Street increased its Agilon Health (AGL) stake by 10% in Q2 2026, buying an estimated $1.73M and bringing the position to 280,126 shares worth $30M. The position accounts for ﹤0.01% of the portfolio, ranked #2154.
State Street first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $82.8M in Q3 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.
- State Street held 280,126 shares of Agilon Health worth $30M as of Q2 2026.
- State Street bought 26,422 Agilon Health shares in Q2 2026, an estimated $1.73M.
- Agilon Health made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2154 holding.
- State Street first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
- State Street's Agilon Health position peaked at $82.8M in Q3 2023.
- 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.